We confirmed that CXCR4 transcription was significantly increased in HBEC-KRASV12high cells after COPD-EVs treatment and that the inhibition of HIF-1α completely abrogated this effect (Fig. 5A). The gene discussed is CXCR4; the disease is chronic obstructive pulmonary disease.